IL22 and neoplasm: IL-22 was the most frequently expressed cytokine (96.8% of patients, Fig. 1a and Figure S1) and showed strong staining in tumour and peritumour matrix tissues (strong expression [ST]: 82.3%) (Fig. 1a and Figure S1).